Tatsuya Takenouchi

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 364 citations · Full text

Surgical Oncology, Medicine, Melanoma +8

A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors

Kuniaki Ohara, Yasuhiro Fujisawa, Koji Yoshino et al. · Journal of Dermatological Science · 2016 · 148 citations

Surgical Oncology, Tnm Staging System, Tumoral Pathology +7

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma

Naoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara et al. · Cancer Science · 2017 · 124 citations · Full text

Cytokine Biomarkers, Immunology, Immunoediting +20

Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients

Kaori Sakaizawa, Atsuko Ashida, Aya Uchiyama et al. · Journal of Dermatological Science · 2015 · 118 citations

Japanese Melanoma Patients, Medicine, Photocarcinogenesis +10

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

Yasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa et al. · Cancer Medicine · 2019 · 106 citations · Full text